Dermont Pharmaceuticals Private Limited
About Dermont Pharmaceuticals Private Limited
Data last updated:
Dermont Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 26 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2016PTC055064. Its GSTIN is 08AAFCD7118L1ZE (Rajasthan).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Nisha Singhal and Manish Singhal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 248 Sector – 4. Chitrakoot Yojna Near 200 Feet Bypass Chitrakoot, Jaipur, Rajasthan, India – 302021.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.24 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.58 Lakh (net margin 1.3%) and EBITDA of ₹2.7 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dermont Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 248 Sector – 4. Chitrakoot Yojna Near 200 Feet Bypass Chitrakoot, Jaipur, Rajasthan, India – 302021
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Dermont Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dermont Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dermont Pharmaceuticals Private Limited, buy the company report.
Financials of Dermont Pharmaceuticals Private Limited
FY 2025 filings availableDermont Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 14% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dermont Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dermont Pharmaceuticals Private Limited
Dermont Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nisha Singhal | Director | 14 Jul 2022 | 4 Years 3 Months | Current |
| Manish Singhal | Director | 26 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Dermont Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Greatlee Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 7.0% | Sanand, Gujarat, India | |||
| Dermont Pharmaceuticals Private Limitedthis company | ₹1.24 Cr (FY 2025) | ₹1.58 Lakh | 1.3% | 14.0% | Jaipur, Rajasthan, India | |
| Elixolife Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | -22.0% | Pilkhuwa, Uttar Pradesh, India | |||
| Sinista Pharmaceuticals Private Limited | ₹1.23 Cr (FY 2025) | 31.0% | New Delhi, Delhi, India | |||
| Unisarsh Pharmaceuticals Private Limited | ₹1.23 Cr (FY 2025) | 5.0% | Patna, Bihar, India |
To see the full peer comparison of Dermont Pharmaceuticals Private Limited, buy the company report.
Auditor
Dermont Pharmaceuticals Private Limited is audited by MITRA SHARMA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MITRA SHARMA & ASSOCIATES | FY 2017 | 016742C |
Shareholding
The shareholding of Dermont Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Dermont Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dermont Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dermont Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dermont Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAFCD7118L1ZE | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dermont Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dermont Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Shyamvati Singhal ceased to be Director on 15 Jul 2022.
Frequently asked questions
Dermont Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in specialty, within the trading industry. It was incorporated on 26 May 2016 (10+ years old) and is registered under CIN U51909RJ2016PTC055064.
Dermont Pharmaceuticals has 2 current directors:
- Nisha Singhal - Director
- Manish Singhal - Director
The latest financial statements of Dermont Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Dermont Pharmaceuticals is 08AAFCD7118L1ZE, registered in Rajasthan.
The CIN (Corporate Identification Number) of Dermont Pharmaceuticals is U51909RJ2016PTC055064. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dermont Pharmaceuticals was incorporated on 26 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Dermont Pharmaceuticals by revenue are Greatlee Pharmaceuticals Private Limited, Elixolife Pharmaceuticals Private Limited, Sinista Pharmaceuticals Private Limited, Unisarsh Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Shyamvati Singhal ceased to be Director on 15 Jul 2022. Nisha Singhal was appointed as Director on 14 Jul 2022. Manish Singhal was appointed as Director on 26 May 2016.
The registered office of Dermont Pharmaceuticals is at A – 248 Sector – 4. Chitrakoot Yojna Near 200 Feet Bypass Chitrakoot, Jaipur, Rajasthan, India – 302021.
Dermont Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Dermont Pharmaceuticals is compliant as of 03 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
